Cargando…
Understanding the cellular interactome of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is reaching epidemic proportions, with a global prevalence of 25% in the adult population. Non-alcoholic steatohepatitis (NASH), which can lead to cirrhosis, has become the leading indication for liver transplantation in both Europe and the USA. Liver fibros...
Autores principales: | Wallace, Sebastian J., Tacke, Frank, Schwabe, Robert F., Henderson, Neil C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284456/ https://www.ncbi.nlm.nih.gov/pubmed/35845296 http://dx.doi.org/10.1016/j.jhepr.2022.100524 |
Ejemplares similares
-
The Potential Role of Cellular Senescence in Non-Alcoholic Fatty Liver Disease
por: Engelmann, Cornelius, et al.
Publicado: (2022) -
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
por: Lefere, Sander, et al.
Publicado: (2019) -
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention
por: Tacke, Frank, et al.
Publicado: (2021) -
The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
por: Kohlhepp, Marlene Sophia, et al.
Publicado: (2023) -
Pediatric Non-Alcoholic Fatty Liver Disease
por: Delvin, Edgard, et al.
Publicado: (2015)